Ramipril 1.25mg Tablet in PCD pharma franchise in Hyderabad

Ramipril 1.25mg Tablet in pharmaceutical manufacturing company in Mumbai

Ramipril 1.25mg Tablet in cardiac care pharma franchise in Pune

Ramipril 1.25mg Tablet in pharma suppliers in Delhi

Ramipril 1.25mg Tablet in pharma export companies in Kolkata
Ramipril 1.25mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /ramipril-5-mg-hydrochlorothiazide-12-point-5-mg-tablet

Ramipil H Tablet

Composition : Ramipril 5 mg + Hydrochlorothiazide 12.5 mg tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Ramipil H Tablet is a fixed-dose combination of Ramipril (5 mg), an ACE inhibitor, and Hydrochlorothiazide (12.5 mg), a thiazide diuretic. This combination is effective in the management of essential hypertension by reducing blood volume and relaxing blood vessels. Ramipril lowers blood pressure by inhibiting the renin-angiotensin system, while Hydrochlorothiazide enhances the removal of excess salt and water, further aiding in blood pressure control and preventing cardiovascular events.

Read More

About the Product

Ramipil H Tablet is a fixed-dose combination of Ramipril (5 mg), an ACE inhibitor, and Hydrochlorothiazide (12.5 mg), a thiazide diuretic. This combination is effective in the management of essential hypertension by reducing blood volume and relaxing blood vessels. Ramipril lowers blood pressure by inhibiting the renin-angiotensin system, while Hydrochlorothiazide enhances the removal of excess salt and water, further aiding in blood pressure control and preventing cardiovascular events.

Commonly reported side effects include dizziness, headache, fatigue, dry cough, and increased urination. Some patients may experience electrolyte imbalances, low blood pressure, or gastrointestinal discomfort. Rarely, allergic reactions or kidney function disturbances may occur.

Ramipil H Tablet is indicated for the treatment of essential hypertension, especially in patients whose blood pressure is not adequately controlled by monotherapy. It is also used to lower the risk of stroke, heart attack, and other cardiovascular complications in hypertensive individuals.

To be used only under the supervision of a qualified healthcare provider. Avoid during pregnancy and in patients with known hypersensitivity to ACE inhibitors or thiazides. Regular monitoring of blood pressure, kidney function, and electrolyte levels is advised. Do not discontinue medication without medical advice.

Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation